Voleon Capital Management LP
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1479847
BERKELEY, CA
Position in AMRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,779,476
-$1,065,117 QoQ
Shares Held
786,764
-8.6% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 78.58366676665429.ToString("F0")%
Shared 0.ToString("F0")%
None 21.416333233345703.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Voleon Capital Management LP holds $39,182,978 across 13 Drug Manufacturers - Specialty & Generic names. AMRX ranks #1 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
786,764 | $9,779,476 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
120,385 | $5,796,537 | |
| 3 | ESPR |
Esperion Therapeutics, Inc.
|
1,916,698 | $5,251,752 | |
| 4 | ZTS |
Zoetis Inc.
|
34,035 | $4,023,277 | |
| 5 | VTRS |
Viatris Inc
|
281,157 | $3,798,431 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
164,921 | $3,423,759 | |
| 7 | ADCT |
ADC Therapeutics SA
|
513,831 | $1,926,866 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
3,105 | $1,841,202 |
All Filings in AMRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,779,476 | 786,764 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,844,593 | 860,682 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,125,911 | 412,179 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $502,105 | 62,065 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $388,731 | 46,388 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $443,219 | 55,962 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||